$45.91 0.00 (%) NPS Pharmaceuticals Inc - NASDAQ

Jan. 29, 2015 | 04:00 PM

Partner Headlines

  1. Shire Set To Acquire NPS Pharmaceuticals for $5.2 Billion

    GuruFocus | Jan. 15, 2015 | 14:29PM EST
  2. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  3. Meet 5 Top Medical Stocks Making Waves This Week

    IBD | Jan. 14, 2015 | 08:02AM EST
  4. Wall Street's Wheelings And Dealings

    Benzinga | Jan. 13, 2015 | 14:49PM EST
  5. UPDATE: Barclays Capital Downgrades NPS Pharmaceuticals After Announced Acquisition By Shire

    Benzinga | Jan. 13, 2015 | 09:23AM EST
  6. Shire Agrees To Acquire NPS Pharmaceuticals

    IBD | Jan. 12, 2015 | 14:26PM EST
  7. Mid-Day Market Update: Foundation Medicine Shares Jump Following Deal With Roche; Crude Oil Slides Over 4%

    Benzinga | Jan. 12, 2015 | 12:55PM EST
  8. Mid-Morning Market Update: Markets Tumble; Shire To Acquire NPS Pharmaceuticals For $5.2 Billion

    Benzinga | Jan. 12, 2015 | 11:37AM EST
  9. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  10. Benzinga's Volume Movers

    Benzinga | Jan. 12, 2015 | 10:20AM EST
  11. Morning Market Losers

    Benzinga | Jan. 12, 2015 | 09:54AM EST
  12. Morning Market Gainers

    Benzinga | Jan. 12, 2015 | 09:42AM EST
  13. UPDATE: Jefferies Raises Price Target On NPS Pharmaceuticals Ahead Of Acquisition By Shire

    Benzinga | Jan. 12, 2015 | 09:00AM EST
  14. Benzinga's Top Downgrades

    Benzinga | Jan. 12, 2015 | 08:43AM EST
  15. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 12, 2015 | 08:15AM EST
  16. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 12, 2015 | 08:03AM EST
  17. Canaccord Genuity Downgrades NPS Pharmaceuticals To Hold

    Benzinga | Jan. 12, 2015 | 07:20AM EST
  18. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Jan. 12, 2015 | 07:14AM EST
  19. Must Watch Stocks for January 12, 2015

    Benzinga | Jan. 12, 2015 | 04:07AM EST
  20. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 11, 2015 | 19:23PM EST
  21. Shire To Acquire NPS Pharmaceuticals for $5.2 Billion

    Benzinga | Jan. 11, 2015 | 15:53PM EST
  22. What Investors Should Expect From Rockwell Medical's Next FDA Decision

    Benzinga | Jan. 7, 2015 | 16:22PM EST
  23. What Investors Are Looking For In NPS Pharmaceuticals Ahead Of A Potential Sale

    Benzinga | Jan. 6, 2015 | 12:34PM EST
  24. UPDATE: Barclays Capital Initiates Coverage On NPS Pharmaceuticals Ahead Of Natpara Launch

    Benzinga | Jan. 6, 2015 | 10:11AM EST
  25. Benzinga's M&A Chatter for Monday January 5, 2015

    Benzinga | Jan. 5, 2015 | 17:36PM EST
  26. Report: NPS Pharmaceuticals Headed For Block

    Benzinga | Jan. 5, 2015 | 15:32PM EST
  27. New Biotech ETF From ALPS

    Benzinga | Jan. 2, 2015 | 08:05AM EST
  28. Benzinga's M&A Chatter for Wednesday December 17, 2014

    Benzinga | Dec. 17, 2014 | 19:17PM EST
  29. NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report

    Benzinga | Dec. 17, 2014 | 11:15AM EST
  30. Morning Market Losers

    Benzinga | Oct. 24, 2014 | 09:54AM EST
  31. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 24, 2014 | 08:18AM EST
  32. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  33. Benzinga's Weekend M&A Chatter

    Benzinga | Oct. 19, 2014 | 21:58PM EST
  34. Technology Stocks Down As Rest Of The Market Starts Week Flat

    Benzinga | Sep. 15, 2014 | 17:15PM EST
  35. Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge

    Benzinga | Sep. 15, 2014 | 15:40PM EST
  36. NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer

    Benzinga | Sep. 15, 2014 | 13:24PM EST
  37. Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion

    Benzinga | Sep. 15, 2014 | 11:26AM EST
  38. Morning Market Losers

    Benzinga | Sep. 15, 2014 | 09:48AM EST
  39. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 15, 2014 | 08:15AM EST
  40. US Stock Futures Flat Ahead Of Economic Data

    Benzinga | Sep. 12, 2014 | 07:40AM EST
  41. NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara Biologics License Application

    Benzinga | Sep. 12, 2014 | 07:07AM EST
  42. FDA says NPS drug is effective

    IBD | Sep. 10, 2014 | 18:53PM EST
  43. Stocks Gain As Oil, Euro Continue Sharp Sell Off

    Benzinga | Sep. 10, 2014 | 17:09PM EST
  44. Lands' End Jumps On Strong Quarterly Earnings; GT Advanced Technologies Shares Slide

    Benzinga | Sep. 10, 2014 | 15:29PM EST
  45. U.S. Stocks Rise; Palo Alto Networks Shares Surge On Upbeat Revenue

    Benzinga | Sep. 10, 2014 | 12:48PM EST
  46. Markets Edge Lower; Krispy Kreme Doughnuts Profit Misses Estimates

    Benzinga | Sep. 10, 2014 | 11:22AM EST
  47. Benzinga's Volume Movers

    Benzinga | Sep. 10, 2014 | 10:20AM EST
  48. Morning Market Movers

    Benzinga | Sep. 10, 2014 | 09:39AM EST
  49. FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara For Hypoparathyroidism

    Benzinga | Sep. 10, 2014 | 08:07AM EST
  50. NPS Pharma Initiates Phase 2a Study Of NPSP795 In Adult Patients With Autosomal Dominant Hypocalcemia (ADH)

    Benzinga | Aug. 4, 2014 | 08:13AM EST
Trading Center